AVPN Webinar
Shifts in Chinese Private Sector Giving:
Pandemic Philanthropy, China, and Technology
6 August 2020
10:30 – 11:45 AM (GMT+8)
Since the start of the pandemic, Chinese philanthropists have donated over $250 million towards COVID-19 R&D-related initiatives. This includes funding for R&D around diagnostics, therapeutics as well as the coveted COVID-19 vaccine both within China and abroad. This wave of private donations to health R&D represents a new trend, which has the potential to reshape China’s philanthropic sector and contribute positively to collaborative international efforts.
Bridge Consulting, an AVPN member and a Beijing-based global health and development-focused consultancy, launched its inaugural report on philanthropy titled Pandemic Philanthropy: Exploring Chinese Donors’ Embrace of COVID-19 R&D Funding. To fill gaps in expertise for effective R&D, the Report identifies opportunities for international actors to collaborate locally.
Through the perspectives of a donor, grantee, and R&D expert, this webinar will seek to:
- Share the highlights of the Report that can potentially influence funders’ funding directions
- Explore how China’s research institutes, companies and foundations have contributed to fighting the COVID-19 pandemic
- Call for collaboration among international funders and explore partnership opportunities
Please scan the QR code to read the report:
Read Andre’s blog post How Could COVID-19 Change Philanthropy in China?
SPEAKERS |
Dr. Manchun Lu Chief Operating Officer, Global Health Drug Discovery Institute Manchun joined GHDDI in July 2016 as the Acting Director of Operation and the Secretary of the Board, and now is the COO of the Institute. She worked on GHDDI’s initial setup and has been responsible for its various operational functions as well as external engagement to support its R&D activities and ensure a smooth operation. She has diverse experience in business and management, scientific R&D, and NGO operation. Manchun was trained as a chemist obtaining a PhD Degree from the University of Wisconsin-Madison. She conducted post-doctoral research at Princeton University on single molecule sequencing. She also has an MBA degree from the Anderson School of Management, UCLA. |
|
Ruixi Hao Program Officer, Philanthropic Partnerships, Bill & Melinda Gates Foundation China Country Office Ruixi leads philanthropic partnerships work in China to improve the culture, policy and infrastructure for philanthropic development. She has over seven years of management consulting experience with Monitor Group both at its Beijing and Cambridge offices. Before that, she worked with Procter & Gamble. Ruixi holds a Master’s degree from the Harvard Kennedy School, and Bachelor’s degree from Guanghua School of Management, Peking University. |
|
He Zhang Senior Researcher, Baidu Research USA He leads the computational biology team at Baidu Research USA. His research has mainly focused on RNA structure prediction, RNA design, protein structure prediction, and their medical applications. Recently, he and his team developed LinearDesign, a novel algorithm to improve mRNA vaccine stability and protein production. He has published papers in computational biology top conferences and journals. Before joining Baidu Research, he graduated from Oregon State University in 2018. |
|
Angel Teh Associate Director, Bridge Consulting Angel heads Bridge Consulting’s global health and development efforts with key international clients and partners including Gavi and the Global Partnership for Education. Prior to joining Bridge, she was focused on developing technology strategy at Lenovo’s China headquarters, as well as public policy and government relations for a range of global organizations in the healthcare, technology and NGO sectors at APCO Worldwide in Singapore and Beijing. Angel graduated from Singapore Management University (SMU) with a double major in Political Science and Corporate Communication, and is pursuing a Master’s degree in Public Health (Global Health) at King’s College London. |
|
Moderator: Andre Shen Founder & CEO, Bridge Consulting Andre leads Bridge Consulting’s business strategy and works with clients and partners to develop communications strategies that are aligned with their interests and missions while advancing social good. He has been instrumental in managing the social media channels and campaigns for a variety of well-known non-profit organizations including the Bill & Melinda Gates Foundation, the World Health Organization and the Jack Ma Foundation. Prior to founding Bridge, Andre worked at the Beijing office of Global Health Strategies, a US-based consultancy with ten offices around the world, and a particular focus on digital advocacy and social media. |
PARTNERS |